Systematic (IUPAC) name:8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepine Clinical data Trade names Xanax AHFS/Drugs.com monograph MedlinePlus a684001 Pregnancy category US: D (Evidence of risk) Legal status AU: S8 (Controlled) CA: Schedule IV DE: Anlage III UK: POM (Prescription only) US: Schedule IV UN: Psychotropic Schedule IV ? (Prescription only) Dependence liability High[medical citation needed] Routes of administration Oral, Sublingual Pharmacokinetic data Bioavailability 80–90% Metabolism Hepatic, via Cytochrome P450 3A4 Biological half-life Immediate release: 11.2 hours, Extended release: 10.7–15.8 hours Excretion Renal Identifiers CAS Number 28981-97-7 Yes ATC code N05BA12 PubChem CID: 2118 IUPHAR/BPS 7111 DrugBank DB00404 Yes ChemSpider 2034 Yes UNII YU55MQ3IZY Yes KEGG D00225 Yes ChEBI CHEBI:2611 Yes ChEMBL CHEMBL661 Yes Chemical data Formula C17H13ClN4 Molecular mass 308.77 g·mol?1
Alprazolam , available as the trade name Xanax among others, is a short-acting anxiolytic of the benzodiazepine class. It is commonly used for the treatment of panic disorder, and anxiety disorders, such as generalized anxiety disorder (GAD) or social anxiety disorder (SAD). It was the 12th most prescribed medicine in 2010.Alprazolam, like other benzodiazepines, binds to specific sites on the GABAA receptor. It possesses anxiolytic, sedative, hypnotic, skeletal muscle relaxant, anticonvulsant, and amnestic properties. Alprazolam is available for oral administration in compressed tablet (CT) and extended-release capsule (XR) formulations.